IBRX

ImmunityBio, Inc. IBRX

Individual Beneficiary

Name of reporting person Citizenship or organization Sole voting power Shared voting power Sole dispositive power Shared dispositive power Amount beneficially owned Percent of class Accepted date
dividing (a) the total number of shares of the Issuer’s common stock being reported in this Statemen United States 4685077 0 4685077 0 4685077 12 % 13/02/2018
Sorrento Therapeutics, Inc. Delaware 0 0 0 0 0 0 % 10/02/2017
2 USA 5618326 0 5618326 0 5618326 6.92 % 17/02/2016
2. United States 0 0 0 4485495 4485495 5.5 % 12/02/2016
2. United States 0 0 0 4485495 4485495 5.5 % 12/02/2016

Senat trading

Bureau Date de la transaction Date de réception Type Amount Commentaire

Senat Divulgation

Représentant Date de la transaction Date de divulgation Type Amount District
Daniel Goldman 2023-03-06 2023-04-17 Sale $1,001 - $15,000 NY10